@article{Agrawal_U-2021_43289,
title = {COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study},
author = {Agrawal, U. and Katikireddi, S. and McCowan, C. and Mulholland, R. and Azcoaga-Lorenzo, A. and Amele, S. and Fagbamigbe, A. and Vasileiou, E. and Grange, Z. and Shi, T. and Kerr, S. and Moore, E. and Murray, J. and Shah, S. and Ritchie, L. and O'Reilly, D. and Stock, S. and Beggs, J. and Chuter, A. and Torabi, F. and Akbari, A. and Bedston, S. and McMenamin, J. and Wood, R. and Tang, R. and de Lusignan, S. and Hobbs, F. and Woolhouse, M. and Simpson, C. and Robertson, C. and Sheikh, A.},
month = {sep},
year = {2021},
abstract = {BackgroundThe UK COVID-19 vaccination programme has prioritised vaccination of those at the highest risk of COVID-19 mortality and hospitalisation. The programme was rolled out in Scotland during winter 2020–21, when SARS-CoV-2 infection rates were at their highest since the pandemic started, despite social distancing measures being in place. We aimed to estimate the frequency of COVID-19 hospitalisation or death in people who received at least one vaccine dose and characterise these individuals.},
pages = {1439-1449},
volume = {9},
issue = {12},
journal = {The Lancet Respiratory Medicine},
publisher = {Elsevier},
url = {https://doi.org/10.1016/S2213-2600(21)00380-5},
}
